Status and phase
Conditions
Treatments
About
Umbilical cord blood mononuclear stem cells (UCBMSCs) transplant followed by the intensive locomotor training for up to 5±1 hours a day, 5±1 days a week, and for 3-6 months for treatment in patients with chronic, stable and complete spinal cord injury.
Full description
This study is a randomized controlled, Phase II, two-arm study of Umbilical Cord Blood Mononuclear Cell (MC001) transplant into the injured spinal cord followed by the locomotor training for up to 5±1 hours a day, 5±1 days a week, for 3-6 months. A total of 18 subjects with chronic complete spinal cord injury (SCI) will be randomized to one of the two groups. The subjects assigned to Group A will receive 6.4 million UCBMNC (MC001) transplanted into the dorsal root entry zones above and below the injury site exposed by a laminectomy. Subjects in Group B will not have MC001 transplant or surgery. All subjects will receive 3-6 months of intensive locomotor training.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Note: For the first three subjects at each study center, the neurological level of SCI will be limited to thoracic region (between T1 and T11).
Exclusion criteria
Any contraindication of laminectomy operation or locomotor training includes:
Primary purpose
Allocation
Interventional model
Masking
18 participants in 2 patient groups
Loading...
Central trial contact
Bobo Chen, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal